Rob Dillard

DocwireNews

<p>A new study found overtreating older women (over 70) with breast cancer might be detrimental, while not improving survival or recurrence. The study was published in <em>JAMA Network Open.</em></p>
<p>“As a breast surgeon, I want to give my patients the best chance of survival with the best quality of life,” said senior author Priscilla McAuliffe, M.D., Ph.D., surgical oncologist at UPMC Hillman Cancer Center and attending surgeon in the Department of Surgery at the University of Pittsburgh School of Medicine via a <a href="https://www.upmc.com/media/news/041521-Breast-Ca-Over-70-JAMA-Open">press release</a>. “However, we have found that overtreatment of early-stage breast cancer in older patients may actually cause harm while not improving recurrence or survival rates.”</p>
<div>Researchers assessed data from more than 3,000 women over the age of 70 who were diagnosed with ER-positive, HER2-negative breast cancer from 2010 to 2018. The data were obtained from 15 community and academic sites, and were evaluated with the UPMC Network Cancer Registry.</div>
<div></div>
<div>The investigators looked into the efficacy of two procedures: sentinel lymph node biopsy (SLNB), and radiotherapy (RT). They found that the number of SLNB and RT procedures among patients over age 70 were 65.3% and 54.4%, respectively. Importantly, the researchers observed that the rates of breast cancer recurrence  or survival remained unchanged for treated versus untreated patients.</div>
<div></div>
<div>https://twitter.com/bioengineerorg/status/1382726827140075527</div>
<div></div>
<div>“This study is an example of how we can use big data to deliver on the promise of precision medicine—getting the right treatment to the right patient at the right time,” said Adrian Lee, Ph.D., investigator at the Women’s Cancer Research Center at UPMC Hillman Cancer Center and Magee Womens Research Institute, and director of the UPMC/Pitt Institute of Precision Medicine. “Sometimes—as it happens to be in this case—that could mean deciding not to provide a certain treatment to ensure better care for the patient.”</div>
<div></div>
<div>https://twitter.com/PedsPublisher/status/1382744542860959744</div>
<div></div>
<div>https://twitter.com/7thSpaceCom/status/1382820545566150658</div>
<div></div>
<div></div>
<div></div>


<p>A new study found overtreating older women (over 70) with breast cancer might be detrimental, while not improving survival or recurrence. The study was published in <em>JAMA Network Open.</em></p><p>“As a breast surgeon, I want to give my patients the best chance of survival with the best quality of life,” said senior author Priscilla McAuliffe, M.D., Ph.D., surgical oncologist at UPMC Hillman Cancer Center and attending surgeon in the Department of Surgery at the University of Pittsburgh School of Medicine via a <a href="https://www.upmc.com/media/news/041521-Breast-Ca-Over-70-JAMA-Open">press release</a>. “However, we have found that overtreatment of early-stage breast cancer in older patients may actually cause harm while not improving recurrence or survival rates.”</p><div>Researchers assessed data from more than 3,000 women over the age of 70 who were diagnosed with ER-positive, HER2-negative breast cancer from 2010 to 2018. The data were obtained from 15 community and academic sites, and were evaluated with the UPMC Network Cancer Registry.</div><div></div><div>The investigators looked into the efficacy of two procedures: sentinel lymph node biopsy (SLNB), and radiotherapy (RT). They found that the number of SLNB and RT procedures among patients over age 70 were 65.3% and 54.4%, respectively. Importantly, the researchers observed that the rates of breast cancer recurrence  or survival remained unchanged for treated versus untreated patients.</div><div></div><div>https://twitter.com/bioengineerorg/status/1382726827140075527</div><div></div><div>“This study is an example of how we can use big data to deliver on the promise of precision medicine—getting the right treatment to the right patient at the right time,” said Adrian Lee, Ph.D., investigator at the Women’s Cancer Research Center at UPMC Hillman Cancer Center and Magee Womens Research Institute, and director of the UPMC/Pitt Institute of Precision Medicine. “Sometimes—as it happens to be in this case—that could mean deciding not to provide a certain treatment to ensure better care for the patient.”</div><div></div><div>https://twitter.com/PedsPublisher/status/1382744542860959744</div><div></div><div>https://twitter.com/7thSpaceCom/status/1382820545566150658</div><div></div><div></div><div></div>

Izzah Nawaz

New Genetic Study Identifies Two Key Genes Linked to Ulcerative Colitis Risk

Gastroenterology

David M. Waterhouse, MD, MPH

Clinical Trial Gaps in TNBC: New Data Underscores Access Inequities for Black Women

Triple-Negative Breast Cancer

Sibylle Loibl, MD

How DESTINY-Breast09 Could Reshape HER2+ mBC Care: Insights From Dr. Sibylle Loibl

HER2 Breast Cancer

Latest News

Overtreating Older Women with Breast Cancer May Cause More Harm than Good, Study Finds

Breast Cancer News

A new study found overtreating older women (over 70) with breast cancer might be detrimental, while not improving survival or recurrence. The study was published in JAMA ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Diabetes

Obesity

Metabolic Care Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe